Stockscreener 앱 받기
34.72
2.36%
0.77
전일 마감가:
$33.95
열려 있는:
$34.2
하루 거래량:
414.90K
Relative Volume:
0.30
시가총액:
$2.73B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-46.29
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
-1.00%
1개월 성능:
+9.04%
6개월 성능:
+9.41%
1년 성능:
+2.00%
1일 변동 폭
$33.98
$35.38
1주일 범위
$33.20
$35.66
52주 변동 폭
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
34.73 | 2.67B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
528.24 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
207.11 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
639.43 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.09 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.58 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Can Veracyte Inc. stock beat market expectations this quarterMarket Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
How Veracyte Inc. stock performs in interest rate cyclesBuy Signal & Momentum Based Trading Signals - newser.com
Will Veracyte Inc. benefit from macro trendsWeekly Stock Report & Short-Term High Return Ideas - newser.com
Is Veracyte Inc. stock bottoming out2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Will Veracyte Inc. stock benefit from commodity pricesVolume Spike & Reliable Entry Point Alerts - newser.com
Building trade automation scripts for Veracyte Inc.Stock Surge & Safe Capital Allocation Plans - newser.com
Will Veracyte Inc. stock remain a Wall Street favorite2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Key resistance and support levels for Veracyte Inc.July 2025 Earnings & Long-Term Safe Return Strategies - newser.com
What analyst consensus implies for Veracyte Inc. (12V) stockRate Hike & Technical Confirmation Trade Alerts - newser.com
Veracyte, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Veracyte (VCYT): Assessing Valuation After BALANCE Trial Data and Analyst Upgrades Boost Investor Confidence - Sahm
How high can Veracyte Inc. stock goInsider Buying & Stock Portfolio Risk Control - newser.com
Veracyte Inc. stock daily chart insights2025 Earnings Impact & Real-Time Volume Analysis Alerts - newser.com
Veracyte Inc Stock Analysis and ForecastPrice Volatility Patterns & Rapid Capital Growth - earlytimes.in
What MACD signals say about Veracyte Inc.Trade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Real time social sentiment graph for Veracyte Inc.Layoff News & Daily Volume Surge Trade Alerts - newser.com
Has Veracyte Inc. formed a bullish divergenceJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Why Veracyte Inc. (12V) stock stays on buy listsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Veracyte's (VCYT) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Does Veracyte Inc. qualify in momentum factor screeningJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
How supply chain issues affect Veracyte Inc. stockJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Veracyte (NASDAQ:VCYT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
What analysts say about Veracyte Inc 12V stockStock Price Targets & Superior Capital Trading Plans - earlytimes.in
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte (NASDAQ:VCYT) Insider Sells 8,349 Shares - MarketBeat
Is Veracyte Inc a good long term investmentStock Price Forecasts & Options Trading Analysis Tools - earlytimes.in
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte, Inc. (VCYT) Stock Analysis: 11.33% Potential Upside Amid Robust Diagnostic Innovations - DirectorsTalk Interviews
Will Veracyte (VCYT) Leverage PAM50 Data to Strengthen Its Position in Precision Oncology? - Sahm
Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher’s Clinical Impact - Yahoo Finance
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Why Veracyte Inc. (12V) stock could break out in 2025Weekly Trade Review & Reliable Trade Execution Plans - newser.com
Using data tools to time your Veracyte Inc. exitWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Veracyte Inc. (12V) stock compares with top peersEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Can machine learning forecast Veracyte Inc. recoveryQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Veracyte to replace Triumph in S&P SmallCap 600 index - MSN
Insider Sell Alert: John Leite Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte started at buy by UBS, MRD platform cited - MSN
Veracyte Inc. stock outlook for YEAR2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Applying sector rotation models to Veracyte Inc.Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
AMI Asset Management Corp Sells 8,580 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
0.13%
자본화:
|
볼륨(24시간):